CannaHeal 1:1:1, 30ml

CannaHeal 1:1:1

We source only the finest field grown organic high CBD hemp and only highest grade indoor grown organic Cannabis (THC). The high CBD hemp flower is extracted using cryogenic ethanol, and the THC flowers are painstakingly processed with a low temperature rosin pressing technique. This process fully captures all the beneficial ingredients, and allows the THC to largely remain in the non-pyscoactive THCa (acid) form enabling the user to utilise this preparation with limited psychotropic effects.

Elevate your wellness routine with our meticulously crafted CannaHeal tincture, designed for those seeking to support overall natural  health.

Our new and improved CannaHeal 1:1:1 harnesses the entourage effect where cannabinoids work synergistically to amplify their therapeutic potential without any psychoactive effects from THC. 

Our new potent blend features a balanced 10mgTHCa:10mg CBD:10mg CBG formulation. Sourced from high-quality full-spectrum CBD and THCa cannabis extracts, and enhanced with 99.6% pure CBG isolate, this tincture is suspended in organic MCT oil for optimal absorption and bioavailability.

Key Science Backed Therapeutic Benefits:

Understanding the Entourage Effect in Our Tincture

The entourage effect refers to the synergistic interaction among various compounds in cannabis, including cannabinoids like THCa, CBD, and CBG, as well as terpenes and flavonoids present in full-spectrum extracts.

In CannaHeal 1:1:1 the full-spectrum CBD and THCa extracts provide a rich profile of these naturally occurring elements, while the addition of pure CBG isolate potentiates those ingredients. This synergy means the combined effects may be greater than the sum of individual cannabinoids, improving therapeutic outcomes such as reduced inflammation and mood regulation. For instance, terpenes in the full-spectrum components can modulate how cannabinoids bind to receptors in the endocannabinoid system, leading to more balanced and effective results without relying on isolated compounds alone. This holistic approach mirrors how Cannabis works in nature, offering a more comprehensive wellness experience.

Anti-Inflammatory Support

THCa, the non-intoxicating precursor to THC, is renowned for its potent anti-inflammatory properties, which may help alleviate discomfort associated with chronic conditions like arthritis or muscle strain.

Combined with CBD’s well-documented ability to modulate inflammatory responses and CBG’s role in inhibiting pro-inflammatory pathways, this blend offers comprehensive relief to promote daily comfort and mobility.

Neuroprotective and Cognitive Wellness

CBG is often called the “mother cannabinoid,” and shows promise in supporting brain health by protecting neural cells from oxidative stress. Paired with THCa’s neuroprotective qualities and CBD’s potential to enhance neuroplasticity, this tincture aids in maintaining cognitive clarity, reducing oxidative damage, and supporting mental resilience against everyday stressors.

Mood and Stress Management

CBD is widely studied for its anxiolytic effects, helping to balance serotonin levels for a calmer state of mind. THCa contributes by promoting relaxation, while CBG enhances mood regulation through its interaction with the endocannabinoid system. Together, synergistically they provide a gentle, non-sedating approach to managing stress, anxiety, and emotional well-being.

Digestive and Appetite Harmony

CBG’s antibacterial properties support gut health by combating harmful bacteria, making it beneficial for conditions like IBS or inflammatory bowel disorders. THCa’s anti-emetic effects can help soothe digestive upset, and CBD’s role in regulating gut motility rounds out this trio for improved appetite stimulation and overall gastrointestinal comfort.

Enhanced Bioavailability in Organic MCT Oil

Our base of certified organic medium-chain triglyceride (MCT) oil ensures rapid absorption, allowing the cannabinoids to enter your system efficiently for faster, more effective results. This carrier oil also supports sustained energy and metabolic health, complementing the tincture’s holistic benefits.

Experience the difference today!  Make your order and unlock the therapeutic synergy of premium cannabinoids.

References

1. Nahler G. Decoding the Postulated Entourage Effect of Medicinal Cannabis. “Pharmacology Research & Perspectives”. August 21, 2023. https://pmc.ncbi.nlm.nih.gov/articles/PMC10452568/
2. New Study Shows Clinical Evidence of the Entourage Effect as D-Limonene and THC Reduce Anxiety. “Drexel University Cannabis Research”. April 10, 2024. https://drexel.edu/cannabis-research/research/research-highlights/2024/April/study-shows-clinical-evidence-entourage-effect-thc-limonene/
3. Santiago M, et al. Does the “Entourage Effect” in Cannabinoids Exist? A Narrative Scoping Review. “Cannabis and Cannabinoid Research”. 2023. https://www.liebertpub.com/doi/10.1089/can.2023.0052
4. The Entourage Effect in Cannabis Medicinal Products: A Comprehensive Review. “International Association for the Study of Pain (IASP)”. November 17, 2024. https://www.iasp-pain.org/publications/pain-research-forum/papers-of-the-week/paper/the-entourage-effect-in-cannabis-medicinal-products-a-comprehensive-review/
5. Gibson LP, et al. Study Shows Cannabis Terpenes Provide Pain Relief, Contribute to ‘Entourage Effect’. “University of Arizona Health Sciences”. July 14, 2021. https://healthsciences.arizona.edu/news/releases/study-shows-cannabis-terpenes-provide-pain-relief-contribute-entourage-effect
6. Worthen DR. The Case for the Entourage Effect and Conventional Breeding of Clinical Cannabis. “Frontiers in Plant Science”. January 8, 2019. https://www.frontiersin.org/journals/plant-science/articles/10.3389/fpls.2018.01969/full
7. What is the entourage effect and is it beneficial? “Medical News Today”. August 19, 2024. https://www.medicalnewstoday.com/articles/entourage-effect
8. Russo EB. Cannabis-Based Medicines and Pain: A Review of Potential Synergistic and Entourage Interactions. “Pain Management”. 2021. https://www.tandfonline.com/doi/full/10.2217/pmt-2020-0110
9. Zimmer A. Some of the Parts: Is Marijuana’s “Entourage Effect” Scientifically Valid? “Scientific American”. April 20, 2017. https://www.scientificamerican.com/article/some-of-the-parts-is-marijuana-rsquo-s-ldquo-entourage-effect-rdquo-scientifically-valid/
10. Anderson LL, et al. The Cannabinoids, CBDA and THCA, Rescue Memory Deficits and Reduce Amyloid-Beta and Tau Pathology in an APPxPS1 Transgenic Mouse Model of Alzheimer’s Disease. “Journal of Alzheimer’s Disease”. April 6, 2023. https://pmc.ncbi.nlm.nih.gov/articles/PMC10095267/
11. Palomares B, et al. Tetrahydrocannabinolic acid A (THCA-A) reduces adiposity and prevents metabolic disease caused by diet-induced obesity. “Biochemical Pharmacology”. 2019. https://www.sciencedirect.com/science/article/abs/pii/S0006295219303922
12. Nallathambi R, et al. Anti-Inflammatory Activity in Colon Models Is Derived from Δ9-Tetrahydrocannabinolic Acid That Interacts with Additional Compounds in Cannabis Extracts. “Cannabis and Cannabinoid Research”. 2017. https://pmc.ncbi.nlm.nih.gov/articles/PMC5627671/
13. Atalay S, et al. Antioxidative and Anti-Inflammatory Properties of Cannabidiol. “Antioxidants”. 2020. https://pmc.ncbi.nlm.nih.gov/articles/PMC7023045/
14. Burstein S. Cannabidiol (CBD) and its analogs: a review of their effects on inflammation. “Bioorganic & Medicinal Chemistry”. April 1, 2015. https://www.sciencedirect.com/science/article/abs/pii/S0968089615000838
15. CBD for Arthritis Pain: What You Should Know. “Arthritis Foundation”. No date. https://www.arthritis.org/health-wellness/healthy-living/managing-pain/pain-relief-solutions/cbd-for-arthritis-pain
16. Vukic V, et al. Regulation of inflammatory pathways by cannabigerol in collagen-induced arthritis in rats. “Frontiers in Pharmacology”. October 27, 2025. https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1705962/full
17. Nachnani R, et al. Cannabigerol (CBG): A Comprehensive Review of Its Molecular Targets and Therapeutic Potential. “Molecules”. November 20, 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11597810/
18. Knezic A, et al. Cannabigerol as an anti-inflammatory agent altering the level of pro- and anti-inflammatory cytokines and proteins related to cell death. “Biomedicine & Pharmacotherapy”. 2024. https://www.sciencedirect.com/science/article/pii/S0753332224011703
19. Stone NL, et al. Antioxidant and Neuroprotective Effects Induced by Cannabidiol and Cannabigerol in Rat CTX-TNA2 Astrocytes and Isolated Cortexes. “International Journal of Molecular Sciences”. May 18, 2020. https://pmc.ncbi.nlm.nih.gov/articles/PMC7279038/
20. Valdeolivas S, et al. Efficacy of Cannabigerol, a Non-Psychoactive Cannabinoid, in Huntington’s Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice. “Neurotherapeutics”. July 8, 2018. https://pubmed.ncbi.nlm.nih.gov/29986533/
21. Nachnani R, et al. Cannabigerol (CBG): A Comprehensive Review of Its Molecular Targets and Therapeutic Potential. “Molecules”. 2024.https://www.mdpi.com/1420-3049/29/22/5471
22. Nadal X, et al. Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity. “British Journal of Pharmacology”. 2017. https://pubmed.ncbi.nlm.nih.gov/28853159/
23. What Does THCA Do To The Brain? Key Effects. “Chill Frog CBD”. August 28, 2024. https://chillfrogcbd.com/blogs/chill-frog-blog/what-does-thca-do-to-the-brain
24. Anderson LL, et al. The Cannabinoids, CBDA and THCA, Rescue Memory Deficits and Reduce Amyloid-Beta and Tau Pathology in an APPxPS1 Transgenic Mouse Model of Alzheimer’s Disease. “Journal of Alzheimer’s Disease”. April 6, 2023. https://pmc.ncbi.nlm.nih.gov/articles/PMC10095267/
25. Campos AC, et al. Repeated cannabidiol treatment affects neuroplasticity and endocannabinoid signaling in the prefrontal cortex of the Flinders Sensitive Line rat model of depression. “Neuropharmacology”. May 1, 2024. https://www.sciencedirect.com/science/article/abs/pii/S0028390824000376
26. Linge R, et al. Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders. “Frontiers in Pharmacology”. 2017. https://pmc.ncbi.nlm.nih.gov/articles/PMC5441138/
27. Colizzi M, et al. Cannabidiol and brain function: current knowledge and future perspectives. “Frontiers in Pharmacology”. 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC10823027/
28. Sales AJ, et al. Antidepressant-like effect induced by Cannabidiol is dependent on brain serotonin levels. “Progress in Neuro-Psychopharmacology and Biological Psychiatry”. 2018. https://www.sciencedirect.com/science/article/pii/S0278584618301167
29. Skelley JW, et al. Use of Cannabidiol for the Treatment of Anxiety: A Short Synthesis of Pre-Clinical and Clinical Evidence. “Journal of the American Pharmacists Association”. 2020. https://pmc.ncbi.nlm.nih.gov/articles/PMC7480724/
30. The potential of cannabidiol (CBD) as a treatment for anxiety disorders. “Open Access Journal of Addiction and Psychology”.  https://www.openaccessjournals.com/articles/title-the-potential-of-cannabidiol-cbd-as-a-treatment-for-anxiety-disorders-16216.html
31. Rock EM, et al. Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinus. “British Journal of Pharmacology”. 2013. https://pmc.ncbi.nlm.nih.gov/articles/PMC3792001/
32. Nachnani R, et al. Cannabigerol (CBG): A Comprehensive Review of Its Molecular Targets and Therapeutic Potential. “Molecules”. November 20, 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11597810/
33. Blessing EM, et al. Cannabidiol as a Potential Treatment for Anxiety Disorders. “Neurotherapeutics”. 2015. https://pmc.ncbi.nlm.nih.gov/articles/PMC4604171/ (Note: This aligns with serotonin modulation studies.)
34. Wei D, et al. High Cannabigerol Hemp Extract Moderates Colitis and Modulates the Microbiome in an Inflammatory Bowel Disease Model in Mice. “Plants”. 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11338277/
35. Borrelli F, et al. Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease. “Biochemical Pharmacology”. 2013. https://www.sciencedirect.com/science/article/abs/pii/S0006295213000543
36. CBG for Gut Health: Natural Support for Digestive Wellness. “Emerald Bay Extracts”. December 23, 2024. https://www.emeraldbayextracts.com/cbg-for-gut-health-natural-support-for-digestive-wellness
37. Rock EM, et al. Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinus. “British Journal of Pharmacology”. 2013. https://pmc.ncbi.nlm.nih.gov/articles/PMC3792001/
38. What Is THCA? Tetrahydrocannabinolic Acid. “The Hemp Doctor”. April 20, 2023. https://thehempdoctor.com/blog/what-is-thca/
39. Ajetunmobi AO, et al. Cannabidiol and Intestinal Motility: a Systematic Review. “Current Developments in Nutrition”. 2023. https://pmc.ncbi.nlm.nih.gov/articles/PMC10541995/
40. Effects of Cannabinoids on Intestinal Motility, Barrier Permeability, and Therapeutic Potential in Gastrointestinal Diseases. “International Journal of Molecular Sciences”. June 18, 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11203611/